Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company amp biosimilars AG
DescriptionUndisclosed biosimilar
Molecular Target
Mechanism of ActionAntibody; Biosimilar
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat undisclosed immunological condition(s)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today